Cerluten has published research citations on file; Testagen does not yet — the main evidence gap between them.
Cerluten
Evidence
Testagen
Evidence
| Your goal | Better option |
|---|---|
| Has published research citations | Cerluten |
| More provider options (1 vs 0) | Cerluten |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Cerluten
Testagen
About Cerluten
CNS-targeted peptide complex that modulates neuronal gene expression. Shown in Russian clinical studies to improve memory consolidation, attention, and protect against neurodegeneration.
About Testagen
Khavinson-class tetrapeptide bioregulator derived from testicular tissue; proposed to modulate gene expression in Leydig and Sertoli cells; investigated for age-related testicular function decline
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Cerluten
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Testagen
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Cerluten
Not enough vendor pricing yet.
Testagen
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 20, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Cerluten vs Testagen — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/cerluten/testagen